Generics

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Generics for sale

72117 products found

Filters

clindamycin phosphate + benzoyl peroxide

Gel 10mg/ml + 50 mg/ml; 10mg/ml + 30 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Austria , France , Germany , Italy , Poland , Portugal , Spain , United Arab Emirates , United Kingdom
Available for
Licensing with supply, Distribution only, Technology transfer
Comments
Cold chain
Manufacturer #17527

The EU pharmaceutical manufacturer stands at the forefront of the global healthcare industry, operating in 60 markets worldwide. Specializing in key therapeutic areas such as Cold and Flu, Ophthalmology, and Dermatology. Notably, they have pioneered the world's first portfolio of microplastic-free nasal care products. With 25 years of ophthalmological expertise, the company possesses a cutting-edge technological platform for developing and producing highly demanding sterile solutions, reinforcing its position as a leader in pharmaceutical innovation.

Manufacturer usually replies in 10 days

minoxidil

Cutaneous solution 20 mg/ml, 50 mg/ml - 60 ml, 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ethiopia , Iraq , Netherlands , Oman , Poland , Portugal , Qatar , Saudi Arabia , Sudan , United Arab Emirates , Vietnam
Registered in
Kazakhstan , Poland , Portugal , Vietnam
Available for
Licensing with supply
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

latanoprost

Eye drops 50 mcg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Preservative free formulation in multidose container. Registration in process DCP EU
Manufacturer #17527

The EU pharmaceutical manufacturer stands at the forefront of the global healthcare industry, operating in 60 markets worldwide. Specializing in key therapeutic areas such as Cold and Flu, Ophthalmology, and Dermatology. Notably, they have pioneered the world's first portfolio of microplastic-free nasal care products. With 25 years of ophthalmological expertise, the company possesses a cutting-edge technological platform for developing and producing highly demanding sterile solutions, reinforcing its position as a leader in pharmaceutical innovation.

Manufacturer usually replies in 10 days

penicillamine

Tablets 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

xylometazoline hydrochloride + ipratropium bromide

Nasal spray 0.5 mg/ml + 0.6 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only, Technology transfer
Comments
PATENTED FORMULATION.MULTI SYMPTOM RELIEF. Relieves nasal congestion and reduces rhinorrhea simultaneously. Superior action when given concurrently in the combined product compared to each component alone. Preservative free → doesn`t burn nasal mucosa
Manufacturer #17527

The EU pharmaceutical manufacturer stands at the forefront of the global healthcare industry, operating in 60 markets worldwide. Specializing in key therapeutic areas such as Cold and Flu, Ophthalmology, and Dermatology. Notably, they have pioneered the world's first portfolio of microplastic-free nasal care products. With 25 years of ophthalmological expertise, the company possesses a cutting-edge technological platform for developing and producing highly demanding sterile solutions, reinforcing its position as a leader in pharmaceutical innovation.

Manufacturer usually replies in 10 days

tobramycin

Ampoules, injection 300 mg/5 ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Italy , Portugal , United Kingdom , Vietnam
Registered in
France , Germany , Italy , Portugal , United Kingdom
Comments
Cold chain product (2-8ªC). No stability zone 4 data required.
Manufacturer #15084

Manufacturer usually replies in 18 days

ropivacaine hydrochloride

Bags for injection/infusion 2 mg/ml - 100 ml, 200 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Belgium , France , Germany , Italy , Portugal , United Kingdom , Vietnam
Registered in
Belgium , France , Germany , Italy , Netherlands , Portugal , United Kingdom
Manufacturer #15084

Manufacturer usually replies in 18 days

levofloxacin hemihydrate

Bags for injection/infusion 5 mg/ml - 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , United Kingdom , Vietnam
Registered in
Belgium , France , Germany , Italy , Netherlands , United Kingdom
Available for
Licensing with supply
Manufacturer #15084

Manufacturer usually replies in 18 days

simethicone

Oral solution 105 mg/ml - 25 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Sudan
Registered in
Portugal
Available for
Licensing with supply
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

aciclovir

Cream 50 mg/g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Australia , Portugal , Sudan , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

ibuprofen

Oral suspension 20 mg/ml - 100 ml, 200 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Libya , Portugal , Sudan , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

paracetamol

Suppositories 125 mg, 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Kosovo , Portugal , Sudan , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

paracetamol

Oral solution 24 mg/ml - 100 ml, 200 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Sudan , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
MAs for sale
Portugal
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

aciclovir

Tablets 200 mg, 400 mg, 800 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Sudan , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

paracetamol + caffeine

Tablets 500 mg + 65 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Sudan , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

levetiracetam

Vials, injection 100 mg/ml - 7 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Belgium , France , Germany , Italy , Netherlands , Portugal , United Kingdom , Vietnam
Registered in
Belgium , France , Germany , Italy , Netherlands , Portugal , Spain , United Kingdom
Manufacturer #15084

Manufacturer usually replies in 18 days

xylometazoline + sea water

Nasal spray 1 mg/ml, 0.5 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Bosnia And Herzegovina , Croatia , North Macedonia , Montenegro , Russia , Slovenia
Available for
Licensing with supply, Distribution only, Technology transfer
Comments
A new generation of nasal decongestants, enhanced by the synergy of medicine and the Adriatic Sea. While xylomethazoline decongests, seawater improves natural nasal cleaning system. Preservative free → doesn`t burn nasal mucosa
Manufacturer #17527

The EU pharmaceutical manufacturer stands at the forefront of the global healthcare industry, operating in 60 markets worldwide. Specializing in key therapeutic areas such as Cold and Flu, Ophthalmology, and Dermatology. Notably, they have pioneered the world's first portfolio of microplastic-free nasal care products. With 25 years of ophthalmological expertise, the company possesses a cutting-edge technological platform for developing and producing highly demanding sterile solutions, reinforcing its position as a leader in pharmaceutical innovation.

Manufacturer usually replies in 10 days

xylometazoline + dexpanthenol

Nasal spray 1 mg/ml + 50 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Croatia , Portugal
Available for
Licensing with supply, Distribution only, Technology transfer
Comments
The ideal combination of two active substances provides fast rhinitis relief with simultaneous regeneration of irritated nasal mucosa, leading to faster recovery. Preservative free → doesn`t burn nasal mucosa
Manufacturer #17527

The EU pharmaceutical manufacturer stands at the forefront of the global healthcare industry, operating in 60 markets worldwide. Specializing in key therapeutic areas such as Cold and Flu, Ophthalmology, and Dermatology. Notably, they have pioneered the world's first portfolio of microplastic-free nasal care products. With 25 years of ophthalmological expertise, the company possesses a cutting-edge technological platform for developing and producing highly demanding sterile solutions, reinforcing its position as a leader in pharmaceutical innovation.

Manufacturer usually replies in 10 days

xylometazoline + hyaluronic acid + sea water

Nasal spray 1 mg/ml, 0.5 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only, Technology transfer
Comments
Quickly and effectively decongests the nose, while hyaluron & seawater provide extra care. Preservative free → doesn`t burn nasal mucosa
Manufacturer #17527

The EU pharmaceutical manufacturer stands at the forefront of the global healthcare industry, operating in 60 markets worldwide. Specializing in key therapeutic areas such as Cold and Flu, Ophthalmology, and Dermatology. Notably, they have pioneered the world's first portfolio of microplastic-free nasal care products. With 25 years of ophthalmological expertise, the company possesses a cutting-edge technological platform for developing and producing highly demanding sterile solutions, reinforcing its position as a leader in pharmaceutical innovation.

Manufacturer usually replies in 10 days

dexmedetomidine

Bags for injection/infusion 4 μg/ml - 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Australia , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , South Africa , Spain , United Kingdom , Vietnam
Registered in
Austria , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , Spain , United Kingdom
Available for
Licensing with supply, Distribution only
Comments
Shelf life: Polypropylene bags - 2 years; PVC-free polyolefin bags - 21 months
Manufacturer #15084

Manufacturer usually replies in 18 days

Want to view all 72117 products? Create your free account today!

CLINDAMYCIN PHOSPHATE

Clindamycin Phosphate is a lincomycin antibiotic. It is used to treat "Acne vulgaris", which is a common to form of acne, consisting of non-inflammatory and mildly inflammatory lesions. Its actions stop the growth of bacteria and help reduce the number of acne lesions. In the severe form of acne, the individual suffers from painful nodules. While Acne is not a serious health issue, it can lead to disfiguring, permanent scarring. It can be very upsetting for people who suffer from the disorder. In the United States alone, more than 17 million people have acne. Clindamycin Phosphate is sold under the brand names Cleocin T,clinda –Derm amongst others. Upjohn and co, first filed for a Clindamycin Phosphate patent in1966, and It was first approved for use in 1968. Bayer and Dupont also filed two different patents during the 80s.

Forms and dose:

Clindamycin Phosphate is available as a lotion, medicated pad, swab, or a foam. To administer the lotion, a thin layer of medication usually applied, twice a day. To use the lotion, the patients are asked to shake the bottle well. To treat using a medicated pad or swab, apply to the affected area gently. More than one pad or swab is used depending on the size of the area to be treated. When using the foam, apply once daily to cover the entire affected area. Careful not spray directly onto your hands or face because the foam will begin to melt on contact with warm skin. The foam may be sprayed directly into the cap or onto a cool surface such as a countertop.

The price of Clindamycin Phosphate:

In the USA, the consumer pays an average retail price of $79.08 for a supply of 30 capsules of 300mg. whereas, in India, Clindamycin Phosphate Gel, weighing 15 grams cost $1.8.

How does it work?

Clindamycin slows and stops the growth of bacteria, decreasing swelling. It kills bacteria by inhibiting protein synthesis at the site of protein synthesis. While clindamycin phosphate is inactive in vitro, rapid in vitro hydrolysis can convert it to clindamycin with antibacterial activity. Clindamycin inhibits bacterial protein synthesis at the ribosomal level by binding to the 50S ribosomal subunit, this affects the process of peptide chain initiation.

Finding Clindamycin Phosphate Manufacturers and Suppliers

The best way to find and gain access to Clindamycin Phosphate manufacturers and Clindamycin Phosphate suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Clindamycin Phosphate can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Clindamycin Phosphate to work with. You can fine-tune your search results using various filters too, letting you search for Clindamycin Phosphate from specific countries.